News
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...
Researchers at the Tohoku University Graduate School of Medicine have uncovered a key primary step in the hepatic ERK pathway ...
Read the paper: Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease As of December, there were 115 clinical trials under way for 83 products derived from pluripotent ...
A team of Chinese scientists has uncovered a key mechanism behind how breast cancer cells weaponise the amino acid arginine to evade the immune system and multiply. Their findings could open up a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results